Drug Information Association Logo

Program Committee

Lynn Bass

 
J. Lynn Bass, PharmD, RPh, Jazz Pharmaceuticals

Larry Blankstein

 
Larry Blankstein, PhD, Genzyme Corporation, A Sanofi Company
 Linda Bowen  
Linda Bowen, MS, RAC, Sanofi US

Jonca Bull

 

Jonca Bull, MD, FDA

Nancie Celini

 

Nancie Celini, DrPH, MPH, CAB Inc.

Nancy Dreyer

 
Nancy Dreyer, PhD, MPH, Quintiles Outcome

Charles Drucker

 
Charles Drucker, MBA, Quest Diagnostics

Lauren Henry Edelstein

 
Lauren Edelstein Henry, MEd, Janssen Pharmaceutical Companies of Johnson & Johnson

Kathy Findlen

 
Kathleen Findlen, Piramal Life Sciences

Ron Fitzmartin

 
Ron Fitzmartin, PhD, MBA, FDA

Michael Folkendt

 
Michael Folkendt, MS, FDA

Stacy Fung

 
Stacey Fung, PharmD, Genentech, A Member of the Roche Group

Garrard Elizabeth

 
Elizabeth Garrard, PharmD, United Therapeutics Corporation

Jonathan Haddad

 
Jonathan Haddad, MPH, MT, Steifel, A GSK Company

Sue Hagen

 
Susan Hagen, National Ataxia Foundation

Deborah Henderson

 
Deborah Henderson, MSN, Merck & Co., Inc.

Alan Hochberg

 
Alan Hochberg, F. Hoffmann-La Roche Ltd., Switzerland

Christopher Hoyle

 

Christopher Hoyle, MBA, Elite Research Network

Rima Izem

 
Rima Izem, PhD, FDA

David Jacobson-Kram

 
David Jacobson-Kram, PhD, FDA

Nirdosh Jagota

 
Nirdosh Jagota, PhD, Genentech, A Member of the Roche Group

Janet Jenkins-Showalter

 
Janet Jenkins-Showalter, Genentech, A Member of the Roche Group

John Kamp

 
John Kamp, PhD, JD, Wiley Rein LLP; Coalition for Healthcare Communication

Mark Kryah

 
Mark Kryah, Eli Lilly and Company

MaryJo Lamberti

 
Mary Jo Lamberti, PhD, MA, Tufts University

Barry Mangum

 
Barry Mangum, PharmD, Duke University Medical Center

Jean-Marie Markham

 
Jean Marie Markham, Clinlogix LLC

Christopher Marrone

 
Christopher Marrone, PharmD, Eli Lilly and Company

Philomena McArthur

 
Philomena McArthur, Johnson & Johnson International

Munish Mehra

 
Munish Mehra, PhD, Quantum Biopharma

Jon Meyer

 
Jon Meyer, Life Science Strategy Group, LLC

Christine Moore

 
Christine Moore, PhD, FDA

Bob Muzerall

 
Bob Muzerall, ForeignExchange Translations

Nancy Myers

 
Nancy Myers, JD, Catalyst Healthcare Consulting, Inc

Ann Oconnell

 
Ann Meeker-O’Connell, MS, Janssen Pharmaceuticals, Inc.

Shaghig Palanjian

 
Shaghig Palanjian, MBA, Shire Human Genetic Therapies, Inc.

Paul Pradip

 
Pradip Paul, MD, MS, Vertex Pharmaceuticals

Kirsten Paulson

 
Kirsten Paulson, The Pew Charitable Trusts

Julia Petses

 
Julia Petses, PharmD, Sanofi US

Kim Quaintance

 
Kim Quaintance, Bayer HealthCare Pharmaceuticals

Badri Rengarajan

 
Badri Rengarajan, MD, Evidera

Janet Rose

Janet L. "Lucy" Rose, MBA, Lucy Rose and Associates, LLC

Abdul Sankoh

 
Abdul Sankoh, Vertex Pharmaceuticals

Suzanne Sensabaugh

 
Suzanne Sensabaugh, MBA, MS, Hartmann Willner LLC

Leigh Shultz

 
Leigh Shultz, PhD, PMP, Merck & Co., Inc.

Maureen Smith

 
Maureen Smith, MEd, Canadian Organization For Rare Disorders (CORD), Canada

Sameer Thapur

 
Sameer Thapar, Rutgers, The State University of New Jersey

Patrick Thomas

 
Patrick Thomas, MS, GlaxoSmithKline

Carolynn Thomas-Jones

 
Carolynn Thomas-Jones, MPH, University of Alabama at Birmingham

Jurgen Venitz

 
Jurgen Venitz, MD, PhD, Virginia Commonwealth University
 Keith Wenzel  
Keith Wenzel, PAREXEL International

Albert Wertheimer

 
Albert Wertheimer, PharmD, PhD, MBA, Temple University

Linda Wood

 
Linda Wood, MPH, MedWrite, Inc.

Program Advisors

Leah Christl 

 

Leah Christl, PhD, FDA

 

Martin Harvey-Allchurch  

Martin Harvey-Allchurch, LLM, European Medicines Agency, European Union

 

Agnes Kein  

Agnes Klein, DrPH, MD, Health Canada

 

Tatsuo Kurokawa  

Tatsuo Kurokawa, PhD, Keio University, Japan

 

Ling Su  

Ling Su, PhD, Sidley Austin LLP, China

 

Toshi Tominaga  

Toshiyoshi Tominaga, PhD, Osaka City University Hospital (OCUH), Japan